These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 17656820)
1. Can studies of aluminum toxicity in vivo and in vitro provide relevant information on the pathogenesis and etiology of Alzheimer's disease? Savory J; Ghribi O J Alzheimers Dis; 2007 Jul; 11(4):429-30; discussion 431-2. PubMed ID: 17656820 [No Abstract] [Full Text] [Related]
2. Aluminum induces tau aggregation in vitro but not in vivo. Mizoroki T; Meshitsuka S; Maeda S; Murayama M; Sahara N; Takashima A J Alzheimers Dis; 2007 Jul; 11(4):419-27. PubMed ID: 17656819 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of aluminum-induced neurodegeneration in animals: Implications for Alzheimer's disease. Savory J; Herman MM; Ghribi O J Alzheimers Dis; 2006 Nov; 10(2-3):135-44. PubMed ID: 17119283 [TBL] [Abstract][Full Text] [Related]
4. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration. Walton JR J Inorg Biochem; 2007 Sep; 101(9):1275-84. PubMed ID: 17662457 [TBL] [Abstract][Full Text] [Related]
5. Aluminum modifies the properties of Alzheimer's disease PHF tau proteins in vivo and in vitro. Shin RW; Lee VM; Trojanowski JQ J Neurosci; 1994 Nov; 14(11 Pt 2):7221-33. PubMed ID: 7525898 [TBL] [Abstract][Full Text] [Related]
6. Aluminium and neuronal cell injury: inter-relationships between neurofilamentous arrays and apoptosis. Savory J; Ghribi O; Forbes MS; Herman MM J Inorg Biochem; 2001 Nov; 87(1-2):15-9. PubMed ID: 11709208 [No Abstract] [Full Text] [Related]
7. Toxic tau oligomer formation blocked by capping of cysteine residues with 1,2-dihydroxybenzene groups. Soeda Y; Yoshikawa M; Almeida OF; Sumioka A; Maeda S; Osada H; Kondoh Y; Saito A; Miyasaka T; Kimura T; Suzuki M; Koyama H; Yoshiike Y; Sugimoto H; Ihara Y; Takashima A Nat Commun; 2015 Dec; 6():10216. PubMed ID: 26671725 [TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease. A new take on tau. Marx J Science; 2007 Jun; 316(5830):1416-7. PubMed ID: 17556561 [No Abstract] [Full Text] [Related]
9. A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model. Bharathi ; Shamasundar NM; Sathyanarayana Rao TS; Dhanunjaya Naidu M; Ravid R; Rao KS Brain Res Rev; 2006 Sep; 52(2):275-92. PubMed ID: 16782202 [TBL] [Abstract][Full Text] [Related]
10. Reversal by desferrioxamine of tau protein aggregates following two days of treatment in aluminum-induced neurofibrillary degeneration in rabbit: implications for clinical trials in Alzheimer's disease. Savory J; Huang Y; Wills MR; Herman MM Neurotoxicology; 1998 Apr; 19(2):209-14. PubMed ID: 9553957 [TBL] [Abstract][Full Text] [Related]
11. Is there any relationship between aluminum and Alzheimer's disease? Eichhorn GL Exp Gerontol; 1993; 28(4-5):493-8. PubMed ID: 8224045 [TBL] [Abstract][Full Text] [Related]
12. Neurofibrillary pathology and aluminum in Alzheimer's disease. Shin RW; Lee VM; Trojanowski JQ Histol Histopathol; 1995 Oct; 10(4):969-78. PubMed ID: 8574016 [TBL] [Abstract][Full Text] [Related]
13. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. Andorfer C; Kress Y; Espinoza M; de Silva R; Tucker KL; Barde YA; Duff K; Davies P J Neurochem; 2003 Aug; 86(3):582-90. PubMed ID: 12859672 [TBL] [Abstract][Full Text] [Related]
14. Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of beta-amyloid protein. Kawahara M; Kato M; Kuroda Y Brain Res Bull; 2001 May; 55(2):211-7. PubMed ID: 11470317 [TBL] [Abstract][Full Text] [Related]